SHANGHAI,March 18,2025-- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV),a leading fintech platform in China,Indonesia and the Philippines,today announced that the
HONG KONG,March 18,2025-- In 2024,Roborock,the global leader in ultra-intelligent home robotics engineered to simplify daily life,ranked once again first in global sales volume and turnover amongst R
CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Feb. 14,2025-- HarbourBioMed (the "Company"; HKEX: 02142),a global biopharmaceutical company committed to the discovery,development,and co
CULVER CITY,Calif.,Feb. 14,2025-- Snail Games (Nasdaq: SNAL),a premier global developer and publisher of interactive digital entertainment,celebrates new milestones that are reshaping the ARK universe
XUN COUNTY,China,Feb. 14,2025-- On February 6,2025,the ninth day of the first lunar month,the 17th Central Plains (Hebi) Folk Culture Festival ushered in the Dapishan Temple Fair. The event was a vibr
BOSTON,Feb. 14,2025-- Bambusa Therapeutics,Inc. (Bambusa),a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders,today announced the successfu
KAWASAKI,Japan,Feb. 13,2025-- Fujitsu today announced the launch of theFujitsu Cloud Service Generative AI Platform. The new service,which combines data confidentiality with the ease of use of the clo
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).